GlassScriptPhysician profile
Christine Mcgill
NPI 1639550007
$1,075.34
in general payments reported to CMS, 2019-2025
19 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $114 · 2021: $54.53 · 2022: $228 · 2023: $210 · 2024: $186 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $225.29 | 2019-2025 | Vaxneuvance, Gardasil 9, Proquad |
| Cranial Technologies, INC | $164.78 | 2020-2025 | Doc Band |
| Alk-Abello, INC | $86.49 | 2024-2025 | Grastek, Odactra, Ragwitek |
| Pfizer INC. | $81.37 | 2019-2024 | |
| Corium, LLC | $73.21 | 2022-2024 | Azstarys |
| Seqirus USA INC | $73.09 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Aytu Biopharma, INC. | $53.94 | 2020-2023 | |
| Ironshore Pharmaceuticals INC. | $53.22 | 2019-2023 | Jornay Pm |
| Glaxosmithkline, LLC. | $49.89 | 2019-2023 | Bexsero |
| Regeneron Healthcare Solutions, INC. | $43.84 | 2025 | Dupixent |
| Amgen INC. | $30.56 | 2020 | |
| Qiagen, LLC | $21.03 | 2021 | |
| Meridian Bioscience INC. | $18.98 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.13 | 2024 | |
| Tris Pharma INC | $17.14 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $16.70 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $16.27 | 2024 | Kristalose |
| Sanofi Pasteur INC. | $16.22 | 2024 | |
| Biogen, INC. | $15.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Mcgill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.